Works matching AU Palomares, Belén

Results: 7

Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Published in:
2017
By:
- Nadal, Xavier;
- Río, Carmen;
- Casano, Salvatore;
- Palomares, Belén;
- Ferreiro‐Vera, Carlos;
- Navarrete, Carmen;
- Sánchez‐Carnerero, Carolina;
- Cantarero, Irene;
- Bellido, Maria Luz;
- Meyer, Stefan;
- Morello, Gaetano;
- Appendino, Giovanni;
- Muñoz, Eduardo;
- Del Río, Carmen;
- Palomares, Belén;
- Ferreiro-Vera, Carlos;
- Sánchez-Carnerero, Carolina;
- Muñoz, Eduardo
Publication type:
journal article
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
Published in:
2018
By:
- Navarrete, Carmen;
- Carrillo-Salinas, Francisco;
- Palomares, Belén;
- Mecha, Miriam;
- Jiménez-Jiménez, Carla;
- Mestre, Leyre;
- Feliú, Ana;
- Bellido, Maria L.;
- Fiebich, Bernd L.;
- Appendino, Giovanni;
- Calzado, Marco A.;
- Guaza, Carmen;
- Muñoz, Eduardo
Publication type:
journal article
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
Published in:
2018
By:
- García, Concepción;
- Gómez-Cañas, María;
- Burgaz, Sonia;
- Palomares, Belén;
- Gómez-Gálvez, Yolanda;
- Palomo-Garo, Cristina;
- Campo, Sara;
- Ferrer-Hernández, Joel;
- Pavicic, Carolina;
- Navarrete, Carmen;
- Luz Bellido, M.;
- García-Arencibia, Moisés;
- Ruth Pazos, M.;
- Muñoz, Eduardo;
- Fernández-Ruiz, Javier
Publication type:
journal article
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.
Published in:
Scientific Reports, 2016, p. 29789, doi. 10.1038/srep29789
By:
- Díaz-Alonso, Javier;
- Paraíso-Luna, Juan;
- Navarrete, Carmen;
- del Río, Carmen;
- Cantarero, Irene;
- Palomares, Belén;
- Aguareles, José;
- Fernández-Ruiz, Javier;
- Bellido, María Luz;
- Pollastro, Federica;
- Appendino, Giovanni;
- Calzado, Marco A.;
- Galve-Roperh, Ismael;
- Muñoz, Eduardo
Publication type:
Article
Δ9 -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors.
Published in:
2020
By:
- Palomares, Belén;
- Garrido‐Rodriguez, Martín;
- Gonzalo‐Consuegra, Claudia;
- Gómez‐Cañas, María;
- Saen‐oon, Suwipa;
- Soliva, Robert;
- Collado, Juan A.;
- Fernández‐Ruiz, Javier;
- Morello, Gaetano;
- Calzado, Marco A.;
- Appendino, Giovanni;
- Muñoz, Eduardo;
- Garrido-Rodriguez, Martín;
- Gonzalo-Consuegra, Claudia;
- Gómez-Cañas, María;
- Saen-Oon, Suwipa;
- Fernández-Ruiz, Javier
Publication type:
journal article
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.
Published in:
2018
By:
- del Rio, Carmen;
- Cantarero, Irene;
- Palomares, Belén;
- Gómez‐Cañas, María;
- Fernández‐Ruiz, Javier;
- Pavicic, Carolina;
- García‐Martín, Adela;
- Luz Bellido, Maria;
- Ortega‐Castro, Rafaela;
- Pérez‐Sánchez, Carlos;
- López‐Pedrera, Chary;
- Appendino, Giovanni;
- Calzado, Marco A.;
- Muñoz, Eduardo;
- Gómez-Cañas, María;
- Fernández-Ruiz, Javier;
- García-Martín, Adela;
- Ortega-Castro, Rafaela;
- Pérez-Sánchez, Carlos;
- López-Pedrera, Chary
Publication type:
journal article
Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration.
Published in:
Translational Neurodegeneration, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40035-019-0148-x
By:
- Aguareles, José;
- Paraíso-Luna, Juan;
- Palomares, Belén;
- Bajo-Grañeras, Raquel;
- Navarrete, Carmen;
- Ruiz-Calvo, Andrea;
- García-Rincón, Daniel;
- García-Taboada, Elena;
- Guzmán, Manuel;
- Muñoz, Eduardo;
- Galve-Roperh, Ismael
Publication type:
Article

Works matching AU Palomares, Belén

Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.

Δ<sup>9</sup> -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB<sub>1</sub> receptors.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB<sub>2</sub> receptor-dependent pathways.

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration.